The U.S. Food and Drug Administration (FDA) issued an emergency use authorization for an experimental new drug called peramivir, made by Biocryst Pharmaceuticals Inc and licensed to Shionogi & Co Ltd as Reuter stated. And this is a guideline about the use of Peramivir IV under Emergency Use Authorization for Health Care Providers in treating 2009 H1N1 Influenza. The article provides brief explanation regarding the use of this neuroaminidase…
Advertisement
Find Your Job
Health Job Site



